VCYT - Veracyte Inc
Veracyte Inc Logo

VCYT - Veracyte Inc

https://www.veracyte.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.

52W High
$47.32
52W Low
$22.61
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
2.07
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
95.38
Forward P/E (<15 better)
25.45
EV/EBITDA (<8 favorable)
43.91
EV/Revenue (<3 favorable)
4.76
P/S (TTM) (<3 favorable)
5.32
P/B (<3 favorable)
2.09
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.52%
Institutions (25–75% balanced)
109.47%
Shares Outstanding
78,672,000
Float
78,228,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
479,129,000
Gross Profit (TTM)
338,021,000
EPS (TTM)
0.34
Profit Margin (>10% good)
0.06%
Operating Margin (TTM) (higher better)
0.11%
ROE (TTM) (>15% strong)
0.02%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.14
Momentum
Bearish momentum
Value
1.2467
Previous
1.3820
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025